InvestorsHub Logo

oldberkeley

04/17/15 8:48 AM

#6517 RE: LasNubes #6515

Looks like a typical over-reaction to me.

Failed both primary and secondary endpoints, did no better than placebo, results even worse than expected, management desperately spinning.

Utter and total disaster, not an over-reaction.

EDIT: Also this from Twitter, could be even worse than management is letting on-

Martin Shkreli ?@MartinShkreli 1h1 hour ago

just realized the post-hoc analysis excludes half of the drug group patients. wow. $ATHX